A novel chromosomal translocation t(3;5)(q12;p15.3) and loss of heterozygosity on chromosome 22 in a multifocal follicular variant of papillary thyroid carcinoma presenting with skin metastases

被引:12
作者
Smit, JWA
Van Zelderen-Bhola, S
Merx, R
De Leeuw, W
Wessels, H
Vink, R
Morreau, H
机构
[1] Leiden Univ, Med Ctr, Dept Endocrinol, NL-2300 RC Leiden, Netherlands
[2] Leiden Univ, Med Ctr, Dept Clin Cytogenet, NL-2300 RC Leiden, Netherlands
[3] Leiden Univ, Med Ctr, Dept Pathol, NL-2300 RC Leiden, Netherlands
关键词
D O I
10.1046/j.1365-2265.2001.01311.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Classic genetic rearrangements in papillary carcinoma of the thyroid involve the RET- or TRK proto-oncogenes. We report a novel chromosomal translocation t(3;5)(q12;p15.3), confirmed by fluorescence in situ hybridization, in a multifocal follicular variant of a papillary carcinoma of the thyroid in a 79-year-old woman, with skin metastases as a presenting symptom. Three years earlier, another cutaneous metastasis on her scalp was misdiagnosed as hidradenoma. Four tumour foci were recognized in the thyroid, two with a follicular variant of papillary carcinoma. To detect loss of heterozygosity, 14 chromosomes were investigated with 59 microsatellite markers. A clonal relationship was detected between the two foci of tumour in the thyroid gland containing follicular variant of papillary carcinoma and one of the skin lesions tested, all demonstrating loss of heterozygosity (LOH) in the same region of chromosome 22. Based on earlier reports, the low rate of LOH detected is in agreement with the diagnosis papillary carcinoma of the thyroid. Whole body scintigraphy performed after ablative therapy with radioiodine revealed multiple metastases in the lungs and skeleton. After repeated radioiodine therapy, thyroglobulin under thyroxine suppression became undetectable and post-therapeutic scintigraphy revealed important regression of metastases.
引用
收藏
页码:543 / 548
页数:6
相关论文
共 21 条
[1]   CYTOGENETIC STUDIES ON 19 PAPILLARY THYROID CARCINOMAS [J].
ANTONINI, P ;
VENUAT, AM ;
CAILLOU, B ;
BERGER, R ;
SCHLUMBERGER, M ;
BERNHEIM, A ;
PARMENTIER, C .
GENES CHROMOSOMES & CANCER, 1992, 5 (03) :206-211
[2]  
Belge G, 1997, Verh Dtsch Ges Pathol, V81, P151
[3]   Thyroid carcinoma metastatic to the skin: A cutaneous manifestation of a widely disseminated malignancy [J].
Dahl, PR ;
Brodland, DG ;
Goellner, JR ;
Hay, ID .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1997, 36 (04) :531-537
[4]   DISTANT METASTASES IN PAPILLARY THYROID-CARCINOMA - 100 CASES OBSERVED AT ONE INSTITUTION DURING 5 DECADES [J].
DINNEEN, SF ;
VALIMAKI, MJ ;
BERGSTRALH, EJ ;
GOELLNER, JR ;
GORMAN, CA ;
HAY, ID .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1995, 80 (07) :2041-2045
[5]  
Fugazzola L, 1996, ONCOGENE, V13, P1093
[6]  
JENKINS RB, 1990, CANCER-AM CANCER SOC, V66, P1213, DOI 10.1002/1097-0142(19900915)66:6<1213::AID-CNCR2820660622>3.0.CO
[7]  
2-9
[8]   Molecular analysis of new subtypes of ELE/RET rearrangements, their reciprocal transcripts and breakpoints in papillary thyroid carcinomas of children after Chernobyl [J].
Klugbauer, S ;
Demidchik, EP ;
Lengfelder, E ;
Rabes, HM .
ONCOGENE, 1998, 16 (05) :671-675
[9]   PAX8-PPARγ1 fusion in oncogene human thyroid carcinoma [J].
Kroll, TG ;
Sarraf, P ;
Pecciarini, L ;
Chen, CJ ;
Mueller, E ;
Spiegelman, BM ;
Fletcher, JA .
SCIENCE, 2000, 289 (5483) :1357-1360
[10]  
MITELMAN F, 1995, RECOMMENDATIONS INT